Stabilized liquid and lyophilized ADAMTS13 formulations

Details for Australian Patent Application No. 2010295299 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Matthiessen, H. Peter; Turecek, Peter L.; Schwarz, Hans-Peter

Agent Pizzeys

Pub. Number AU-A-2010295299

PCT Pub. Number WO2011/035335

Priority 61/244,353 21.09.09 US

Filing date 21 September 2010

Wipo publication date 24 March 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/035335 Priority application(s): WO2011/035335

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010295307-Phentermine liquid dosage form

2010295294-Oxytocin receptor agonists